Referencias - Medtronic MiniMed Manual Del Usuario

APÉNDICE
GUIDO
Mejor control con la bomba desde 2008

REFERENCIAS

1. AmericanDiabetesAssociation.12.ChildrenandAdolescents:StandardsofMedicalCareinDiabetes-2018.Diabetes
Care.2018;41-(suppl1):S126-S136.
2. RodbardH,etal.AmericanAssociationofClinicalEndocrinologistsmedicalguidelinesforclinicalpracticefortheclinical
managementofdiabetesmellitus.EndocrinePtactice.2007;13(1):3-68
3. DiMeglioLA,etal.ISPADClinicalPracticeConsensusGuidelines2018:Glycemiccontroltargetsandglucosemonitoring
forchildren,adolescents,andyoungadultswithdiabetes.PediatricDiabetes.2018;19(Suppl.27):105–114.
4. BecklesZL,EdgeJA,MugglestoneMA,MurphyMSandWalesJK.GuidelinesDevelopmentGroup.Diagnosisand
managementofdiabetesinchildrenandyoungpeople:summaryofupdatedNICEguidance.BMJ2016;352:139
5. PickupJCandRenardE.Long-ActingInsulinAnalogsVersusInsulinPumpTherapyfortheTreatmentofType1andType
2Diabetes.DiabetesCare2008;31(Suppl.2):140-145.
6. BruceW.Bode,MD.FACE.PumpingProtocol;AGuidetoInsulinPumpTherapyInitiation©2012Medtronic,Inc.AllRights
Reserved.
7. BodeB,etal.AlarmsBasedonReal-TimeSensorGlucoseValuesAlertPatientstoHypo-andHyperglycaemia:The
GuardianContinuousMonitoringSystem.DiabetesTechnolTher.2004;6(2):105-113.
8. KaufmanFR,etal.Apilotstudyofthecontinuousglucosemonitoringsystem:clinicaldecisionsandglycemiccontrol
afteritsuseinpediatrictype1diabeticsubjects.DiabetesCare2001;24(12):2030–2034.
9. BergenstalRM,TamborlaneWV,AhmannA,etal.STAR3randomizedcontrolledtrialtocomparesensor-augmented
insulinpumptherapywithmultipledailyinjectionsinthetreatmentoftype1diabetes:Effectivenessofsensor-
augmentedinsulin-pumptherapyintype1diabetes.NEnglJMed.2010;363:311–320.
10. DanneT.etalThePILGRIMStudy:InSilicoModelingofaPredictiveLowGlucoseManagementSystemandFeasibilityin
YouthwithType1DiabetesDuringExercise.DiabetesTechnology&Therapeutics2014;16(6):338-347.
152
| Fundamentos de la terapia con bomba de insulina
11. CongetI.etal.Preventionofhypoglycemiabythepredictivelowglucosemanagementfeatureinauserevaluationstudy.
EASDDiabetologia2015;58(1):416
12. Diabetes.org[Online/Internet].EEUU:AmericanDiabetesAssociation:2013[actualización28deoctubredel2013;
citadoagostode2018]http://www.diabetes.org/living-with-diabetes/parents-and-kids/everyday-life/driving.html
13. PickupJetal.Severehypoglycaemiaandglycemiccontrolintype1diabetes:meta-analysisofmultipledailyinsulin
injectionscomparedwithcontinuoussubcutaneousinsulininfusion.DiabeticMedicine2008;25:765-774.
14. BergenstalRM,etal.Threshold-basedinsulin-pumpinterruptionforreductionofhypoglycaemia.NEJM
2013;369(3):224-32.
15. LyT,etal.Effectofsensor-augmentedinsulinpumptherapyandautomatedinsulinsuspensionvsstandardinsulinpump
therapyonhypoglycaemiainpatientswithtype1diabetes:ArandomisedClinicalTrial.JAMA2013;310(12):1240-1247.
16. Diabetes.org[Online/Internet].EEUU:AmericanDiabetesAssociation:2013[actualización18demarzodel2015;
citadomayode2018]http://www.diabetes.org/living-with-diabetes/complications/ketoacidosis-dka.html
17. Guerci,B.etal.ComparisonofMetabolicDeteriorationbetweenInsulinAnalogandRegularInsulinaftera5-Hour
InterruptionofaContinuousSubcutaneousInsulinInfusioninType1DiabeticPatients.JClinEndocrinolMetab1999;84:
2673–2678
18. JDRF.org[Online/Internet].London(UK):JuvenileDiabetesResearchFoundationLtd:2018[actualizaciónabrilde2018;
citadojuniode2018]https://jdrf.org.uk/about-type-1-diabetes/treating/cgms/
19. AmericanDiabetesAssociation.Standardsofmedicalcareindiabetes--2014.Diabetescare2013;37(Suppl1):S14–80.
20. FreckmannG,etal.JDiabetesSciTechnol2007;1(Issue5)
21. GaryScheinerMS.PostprandialHyperglycemia:It'sAllintheTiming;Post-mealbloodsugarcontroldependsonproper
insulintiming.CDE
22. Joslin.org[Online/Internet].Boston(UUEE):JoslinDiabetesCenter:2019[actualizaciónSeptiembredel2018;citado
mayode2018]http://www.joslin.org/why_is_my_blood_glucose_sometimes_low_after_physical_activity.html
23. urnerBC,JenkinsE,KerrD,SherwinRSandCavanDA.TheEffectofEveningAlcoholConsumptiononNext-Morning
GlucoseControlinType1Diabetes.DiabetesCare2001;24:1888–1893.
24. ZisserH,etal.Boluscalculator:areviewoffour"smart"insulinpumps.DiabetesTechnology&Therapeutics2008;10(6)
25. FrancineR.Kaufman.InsulinPumpsandContinuousGlucoseMonitoring:AUser'sGuidetoEffectiveDiabetes
ManagementAGuidetoPersonalContinuousGlucoseMonitoring.EEUU:AmericanDiabetesAssocaiation;2012
26. PankowskaEetal.Threekindofmealtimeinsulinadministrationandmetaboliccontrolindiabeticchildrenoninsulin
pumps.44thAnnualMeetingofEASD2008.Diabetologia2008;51(Suppl.1):S381
27. K.J.Belletal.ImpactofFat,Protein,andGlycemicIndexonPostprandialGlucoseControlinType1Diabetes:Implications
forIntensiveDiabetesManagementintheContinuousGlucoseMonitoringEra;DiabetesCare2015;38:1008–1015
28. blog.joslin.org[Online/Internet].Boston(UUEE):JoslinDiabetesCenter:2015[actualizaciónSeptiembredel2011;
citadojuliode2018]http://blog.joslin.org/2011/09/why-does-fat-increase-blood-glucose/
29. Medtronic,MiniMedInc.CareLink®PracticalGuideProTherapyManagementSoftwareforDiabetes.2011
30. StrattonIMetal.Associationofglycaemiawithmacrovascularandmicrovascularcomplicationsoftype2diabetes
(UKPDS35):prospectiveobservationalstudy.BMJ2000;321:405-412.
31. EfaluWT,RatnerRE.TheDiabetesControlandComplicationsTrial/EpidemiologyofDiabetesInterventionsand
Complicationsstudyat30years:the"gift"thatkeepsongiving!DiabetesCare2014;37:5–7.
APÉNDICE
Fundamentos de la terapia con bomba de insulina |
153